These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3025996)

  • 1. Sulbactam: biochemical factors involved in its synergy with ampicillin.
    Labia R; Morand A; Lelievre V; Mattioni D; Kazmierczak A
    Rev Infect Dis; 1986; 8 Suppl 5():S496-502. PubMed ID: 3025996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy of sulbactam and ampicillin against methicillin-resistant staphylococci.
    Chin NX; Neu NM; Neu HC
    Drugs Exp Clin Res; 1986; 12(12):939-42. PubMed ID: 3032552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of beta-lactamases by sulbactam and enhanced clinical activity due to target-site binding of the combination of sulbactam and ampicillin.
    Yokota T
    APMIS Suppl; 1989; 5():9-16. PubMed ID: 2786726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T; Tsukamoto K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam.
    Moosdeen F; Williams JD; Yamabe S
    Antimicrob Agents Chemother; 1988 Jun; 32(6):925-7. PubMed ID: 2843088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Fournier MA
    J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
    J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies.
    Cullmann W
    Zentralbl Bakteriol; 1991 Oct; 275(4):500-3. PubMed ID: 1661596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F; Keeble J; Williams JD
    Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH
    J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergism and antagonism in double beta-lactam antibiotic combinations.
    Gutmann L; Williamson R; Kitzis MD; Acar JF
    Am J Med; 1986 May; 80(5C):21-9. PubMed ID: 3487247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Piddock LJ; Traynor EA; Griggs DJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors.
    Maddux MS
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity and kill kinetics of ampicillin/sulbactam (CP-45899) combinations against Escherichia coli and Klebsiella aerogenes.
    Fuglesang JE; Bergan T
    Infection; 1984; 12(1):46-50. PubMed ID: 6323321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death.
    Neu HC
    Am J Med; 1983 Aug; 75(2A):9-20. PubMed ID: 6311012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.